Medical Communications

Showing 15 posts of 6408 posts found.

alexander_hardy

Alexander Hardy returns to Genentech as new CEO

January 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …

Philip Hampton to step down from chairman role at GSK

January 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
dw-anzcxqaqavhl

Head of opioid advisory panel criticises FDA for complacency in ongoing crisis

January 28, 2019 Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma

The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Celgene, NHS, health, pharma, venlytxo

While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …

Bristol-Myers Squibb withdraws lung cancer combo therapy marketing application

January 25, 2019 Medical Communications BMS, Merck, Yervoy, ctla4, lung cancer, opdivo

Bristol-Myers Squibb has been forced to withdraw a marketing application for its combination of Opdivo and Yervoy for lung cancer. …
amgen_flag

China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk

January 25, 2019 Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke

Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …

Diagnosis at stages 1-3 increases cancer survival rate significantly

January 25, 2019 Medical Communications Cancer, England, NHS, health, oncology

Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following …
nhs_sign

NHS App begins public rollout across England following successful testing

January 24, 2019 Medical Communications England, NHS, NHS App, UK, health, pharma

NHS England has announced that the NHS app, which will allow patients to book and manage their GP appointments alongside …
antibiotic_sensitvity_and_resistance

UK government launches plan to control AMR by 2040

January 24, 2019 Medical Communications, Research and Development AMR, Antibiotics, Davos, Matt Hancock, UK

The British government has announced a plan through which it will incentivise pharmaceutical companies to develop drugs aimed at tackling …
mesothelioma

Pushing for progress in mesothelioma

January 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, mesothelioma, pharma

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …
sun-pharma-759

Sun Pharma’s shares hit six-year low after further whistleblower allegations emerge

January 18, 2019 Medical Communications India, Sun Pharma, pharma

Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Netherlands, Novo Nordisk, Roche, astra zeneca, prcing, sequiris, top 10, uk politics

Job switches were the theme of this week as AstraZeneca lost three, high levels executives to biotechs amid a restructuring …

Pharmacists warn of shortages in England

January 18, 2019 Medical Communications access, pharmacists, pricing, shortages

Pharmacists in England have warned that they are struggling to obtain many common generic medicines, as the number of medicines …
novartis_window

Canada Health approves Novartis’ CAR-T therapy Kymriah

January 18, 2019 Medical Communications CAR T, CAR-T, Canada, Cancer, Kymriah, Novartis, oncology

Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and …

Abbvie’s chronic lymphocytic leukaemia drug Venclytxo scores greenlight from NICE

January 18, 2019 Medical Communications, Sales and Marketing AbbVie, NHS, NICE, Venclyxto, leukaemia, pharma

A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s …
The Gateway to Local Adoption Series

Latest content